{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-028272","form_type":"8-K","ticker":"ASTH","cik":"0001083446","company_name":"Astrana Health, Inc.","filed_at":"2022-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.552165+00:00","generated_at":"2026-06-22T07:52:01.255838+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ApolloMed Q3 revenue up 40% to $317M; net income down to $26M; raises full-year guidance","bullets":["Q3 revenue $317M (+40% YoY); net income $26M vs $34.3M; diluted EPS $0.56 vs $0.74.","Adjusted EBITDA $57.1M (revised calculation) vs $62.9M prior year; nine-month revenue $850M (+47%).","Closed acquisition of All American Medical Group (Oct 31) adding >15,000 members; acquired Valley Oaks Medical Group (9 clinics) serving 20,000 patients.","Raised FY2022 revenue guidance to $1.095-1.115B, net income to $50.5-67M, EBITDA to $107.5-133.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-028272","json":"https://secwatch.observer/filing/0001628280-22-028272.json","markdown":"https://secwatch.observer/filing/0001628280-22-028272.md","text":"https://secwatch.observer/filing/0001628280-22-028272.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1083446/000162828022028272/0001628280-22-028272-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1083446/000162828022028272/ameh-20221103.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T07:52:01.255838+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4f24d0b6405ab4642fb61fc94ebdf043a77b0fdf","claim":"Astrana Health, Inc. reported nine months ended September 30, 2022 results: revenue $850.0 million, net income $51.6 million, EPS $1.12. Guidance raised.","evidence_excerpt":"losses from recently acquired IPAs, which it believes to be more reflective of its business. Financial Highlights for Nine Months Ended September 30, 2022: • Total revenue of $850.0 million, up 47% from $578.8 million for the prior-year period • Net income attributable to ApolloMed of $51.6 million, compared to $60.1 million for the prior-year period • EPS-diluted","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1083446/000162828022028272/0001628280-22-028272-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"nine months ended September 30, 2022"},{"label":"Revenue","value":"$850.0 million"},{"label":"Net income","value":"$51.6 million"},{"label":"EPS","value":"$1.12"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"9919c1139f4b52a7a5018ccb4e9932b6062ab88a","claim":"Astrana Health, Inc. reported quarter ended September 30, 2022 results: revenue $317.0 million, net income $26.0 million, EPS $0.56. Guidance raised.","evidence_excerpt":"financial results for the third quarter and nine months ended September 30, 2022. Financial Highlights for Third Quarter Ended September 30, 2022: • Total revenue of $317.0 million, up 40% from $227.1 million for the prior-year quarter • Net income attributable to ApolloMed of $26.0 million, compared to $34.3 million for the prior-year quarter • Earnings","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1083446/000162828022028272/0001628280-22-028272-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter ended September 30, 2022"},{"label":"Revenue","value":"$317.0 million"},{"label":"Net income","value":"$26.0 million"},{"label":"EPS","value":"$0.56"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}